Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies

Simone Scarlata (Rome, Italy), Simone Scarlata, Ombretta Annibali, Simona Santangelo, Francesca Chiodi, Silvia Ferraro, Anna Zito, Maria Cristina Tirindelli, Giuseppe Avvisati, Raffaele Antonelli Incalzi

Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Session: Prognostic factors in pneumonia: from clinical observations to experimental models
Session type: Oral Presentation
Number: 3249
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Simone Scarlata (Rome, Italy), Simone Scarlata, Ombretta Annibali, Simona Santangelo, Francesca Chiodi, Silvia Ferraro, Anna Zito, Maria Cristina Tirindelli, Giuseppe Avvisati, Raffaele Antonelli Incalzi. Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies. Eur Respir J 2015; 46: Suppl. 59, 3249

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary function and respiratory complications in hematopoietic cell transplant
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016


Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016


Poor patient adherence may contribute to increased skin cancer risk in heart and lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


The impact of underlying disease on baseline pulmonary function values after lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016


Utility of biomarkers in the management of respiratory diseases in hematopoietic stem cell transplant
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013


Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Noninfectious pulmonary complications after organ transplantation
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=202
Year: 2005

Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Measured alveolar volume is a marker for mortality risk after acquiring bronchiolitis obliterans following stem-cell transplantation
Source: International Congress 2014 – Respiratory function at rest and during exercise
Year: 2014


Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Incidence, outcomes and risk factors for neoplasms in explanted lungs
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016